Key result
Inactivated Md11/75C vaccine stimulated non-virus-neutralizing antibodies that protected chickens against virulent MDV challenge, but failed to increase titers in previously primed adult chickens.
Why the study?
Does inactivated oil-emulsified Marek's disease vaccine stimulate protective humoral immune responses in chickens?
Does inactivated oil-emulsified Marek's disease vaccine stimulate protective humoral immune responses in chickens?
Virus-neutralizing activity is not a prerequisite for protection against Marek's disease, but maternal immunity derived from hyperimmunized parents is unlikely to control the disease in progeny.
Non-neutralizing antibodies protect chickens from MDV; leaves open maternal immunity efficacy from hyperimmunized parents in progeny.
When inactivated Md11/75C vaccine was inoculated into 1-day-old chickens, it stimulated antibodies detectable by enzyme-linked immunosorbent assay (at a titer of 6400) and indirect fluorescent antibody test (at a titer of 640), but lacking virus-neutralizing activity. Chickens passively inoculated with these antibodies were protected against bursal atrophy, weight loss, and early mortality when challenged with the virulent Md5 strain of Marek's disease virus (MDV). That led to the conclusion that virus-neutralizing activity is not a prerequisite for protection. In another experiment, antibody titers of adult chickens previously primed by exposure to live turkey herpesvirus and MDV did not increase after immunization with inactivated oil-emulsion MDV vaccines. This result provides little hope that Marek's disease can be controlled in progeny chickens by maternal immunity derived from hyperimmunized parents.
No takes yet. Share an insight, caveat, or question.
Lee et al. (1991) studied Marek's disease. Inactivated oil-emulsified Marek's disease vaccine (Md11/75C) was evaluated on Antibody titers and protection against bursal atrophy, weight loss, and early mortality. Inactivated Md11/75C vaccine stimulated non-virus-neutralizing antibodies that protected chickens against virulent MDV challenge, but failed to increase titers in previously primed adult chickens.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: